These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 30878370)

  • 41. Donor Lymphocyte Infusions for Chronic Myeloid Leukemia Relapsing after Allogeneic Stem Cell Transplantation: May We Predict Graft-versus-Leukemia Without Graft-versus-Host Disease?
    Radujkovic A; Guglielmi C; Bergantini S; Iacobelli S; van Biezen A; Milojkovic D; Gratwohl A; Schattenberg AV; Verdonck LF; Niederwieser DW; de Witte T; Kröger N; Olavarria E;
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1230-6. PubMed ID: 25797175
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ex Vivo CD34
    Barba P; Hilden P; Devlin SM; Maloy M; Dierov D; Nieves J; Garrett MD; Sogani J; Cho C; Barker JN; Kernan NA; Castro-Malaspina H; Jakubowski AA; Koehne G; Papadopoulos EB; Prockop S; Sauter C; Tamari R; van den Brink MR; Avecilla ST; Meagher R; O'Reilly RJ; Goldberg JD; Young JW; Giralt S; Perales MA; Ponce DM
    Biol Blood Marrow Transplant; 2017 Mar; 23(3):452-458. PubMed ID: 28017734
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Invasive zygomycosis in patients with graft-versus-host disease after allogeneic stem cell transplantation.
    Leithauser M; Kahl C; Aepinus C; Prall F; Maruschke M; Riemer H; Wolff D; Jost K; Hilgendorf I; Freund M; Junghanss C
    Transpl Infect Dis; 2010 Jun; 12(3):251-7. PubMed ID: 20002357
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic factors identifiable at the time of onset of acute graft-versus-host disease after allogeneic hematopoietic cell transplantation.
    Remberger M
    Haematologica; 2005 Jul; 90(7):870. PubMed ID: 15996922
    [No Abstract]   [Full Text] [Related]  

  • 45. Acquired ichthyosis associated with chronic graft-versus-host disease following allogeneic peripheral blood stem cell transplantation in a patient with chronic myelogenous leukemia.
    Dilek I; Demirer T; Ustün C; Arat M; Koç H; Beksaç M; Erdi H; Anadolu R; Ozcan M; Ilhan O; Akan H
    Bone Marrow Transplant; 1998 Jun; 21(11):1159-61. PubMed ID: 9645582
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Successful management of central nervous system manifestations of chronic graft-vs-host disease: a case report.
    Kundalia R; Hanini A; Kareem SS; Gonzalez R; Gatewood T; Mishra A; Pina Y; Mokhtari S
    Leuk Lymphoma; 2023; 64(8):1485-1489. PubMed ID: 37322898
    [No Abstract]   [Full Text] [Related]  

  • 47. Mismatch on glutathione S-transferase T1 increases the risk of graft-versus-host disease and mortality after allogeneic stem cell transplantation.
    Martínez-Bravo MJ; Calderón-Cabrera C; Márquez-Malaver FJ; Rodríguez N; Guijarro M; Espigado I; Núñez-Roldán A; Pérez-Simón JA; Aguilera I
    Biol Blood Marrow Transplant; 2014 Sep; 20(9):1356-62. PubMed ID: 24844856
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intraoral psoralen ultraviolet A irradiation (PUVA) treatment of refractory oral chronic graft-versus-host disease following allogeneic stem cell transplantation.
    Menillo SA; Goldberg SL; McKiernan P; Pecora AL
    Bone Marrow Transplant; 2001 Oct; 28(8):807-8. PubMed ID: 11781637
    [No Abstract]   [Full Text] [Related]  

  • 49. Pre-engraftment graft-versus-host disease after allogeneic hematopoietic cell transplantation for acute leukemia.
    Lee JH; Lee JH; Kim DY; Yun SC; Kim SD; Choi Y; Lee YS; Kang YA; Jeon MJ; Seol M; Lee KH
    Eur J Haematol; 2011 Aug; 87(2):172-81. PubMed ID: 21599753
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Review of chronic graft-versus-host disease in children after allogeneic stem cell transplantation: nursing perspective.
    Liu YM; Hockenberry M
    J Pediatr Oncol Nurs; 2011; 28(1):6-15. PubMed ID: 20841443
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Skin biopsy in diagnosis of chronic graft-versus-host disease in patients after allogeneic haematopoietic stem cell transplantation: pathologist's point of view on quantitative scoring system].
    Grzanka D; Styczyński J; Debski R; Krenska A; Pacholska M; Prokurat AI; Wysocki M; Marszałek A
    Med Wieku Rozwoj; 2008; 12(4 Pt 2):1105-11. PubMed ID: 19531834
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of graft-versus-host disease-free, relapse-free survival according to a variety of graft sources: antithymocyte globulin and single cord blood provide favorable outcomes in some subgroups.
    Inamoto Y; Kimura F; Kanda J; Sugita J; Ikegame K; Nakasone H; Nannya Y; Uchida N; Fukuda T; Yoshioka K; Ozawa Y; Kawano I; Atsuta Y; Kato K; Ichinohe T; Inoue M; Teshima T;
    Haematologica; 2016 Dec; 101(12):1592-1602. PubMed ID: 27662017
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Autoimmune-Like Hepatitis: A "Hepatitic" Manifestation of Chronic Graft Versus Host Disease in Post-Stem Cell Transplant.
    Baniak NM; Kanthan R
    Int J Surg Pathol; 2016 Apr; 24(2):146-52. PubMed ID: 26464160
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cerebral vasculitis in graft-versus-host disease: a case report.
    Campbell JN; Morris PP
    AJNR Am J Neuroradiol; 2005 Mar; 26(3):654-6. PubMed ID: 15760882
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Allogeneic stem cell transplantation for acute myeloid leukemia with del(7q) following untreated chronic lymphocytic leukemia.
    DeFilipp Z; Huynh DV; Fazal S; Sahovic E
    Hematol Oncol Stem Cell Ther; 2012; 5(3):165-8. PubMed ID: 23095794
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lethal macrophage-related complications of juvenile myelomonocytic leukemia with a blastic crisis: an autopsy case report.
    Satoh T; Kayano H; Watanabe A; Ohta A; Endoh T; Shimizu Y; Fukushima T; Tanaka R; Yasuda M
    Int J Hematol; 2021 Oct; 114(4):517-523. PubMed ID: 34272652
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Graft-versus-leukemia effect after allogeneic bone marrow transplantation for chronic lymphocytic leukemia.
    Rondón G; Giralt S; Huh Y; Khouri I; Andersson B; Andreeff M; Champlin R
    Bone Marrow Transplant; 1996 Sep; 18(3):669-72. PubMed ID: 8879640
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Complications of hematopoietic stem cell transplantation: physiopathology and management. 2. Graft-versus-host disease (GVHD)].
    Morishita Y
    Nihon Naika Gakkai Zasshi; 1998 Aug; 87(8):1502-9. PubMed ID: 9780678
    [No Abstract]   [Full Text] [Related]  

  • 59. Fecal calprotectin in allogeneic stem cell transplantation for the diagnosis of acute intestinal graft versus host disease.
    Bastos Oreiro M; Castilla-Llorente C; de la Guía AL; de Paz R; Van Domselaar M; Nieto J; Rodriguez A; Gallardo D; Canales M;
    Bone Marrow Transplant; 2012 Sep; 47(9):1241-2. PubMed ID: 22307017
    [No Abstract]   [Full Text] [Related]  

  • 60. [Chronic graft-versus-host disease presenting as nephrotic syndrome after allogenic hematopoietic stem cell transplantation].
    Priluckiene J; Kriukelyte I; Jurgutis M; Trociukas I
    Medicina (Kaunas); 2007; 43 Suppl 1():148-52. PubMed ID: 17551294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.